Multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis - a systemic review and meta-analysis
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Blood culture is viewed as the golden standard for the diagnosis of sepsis but suffers from low sensitivity and long turnaround time. LightCycler SeptiFast (LC-SF) is a real-time multiplex polymerase chain reaction test able to detect 25 common pathogens responsible for bloodstream infections within hours. We aim to assess the accuracy of LC-SF by systematically reviewing the published studies. METHOD: Related literature on Medline, Embase, and Cochrane databases was searched up to October 2012 for studies utilizing LC-SF to diagnose suspected sepsis and that provided sufficient data to construct two-by-two tables. RESULTS: A total of 34 studies enrolling 6012 patients of suspected sepsis were included. The overall sensitivity and specificity for LC-SF to detect bacteremia or fungemia was 0·75 (95% CI: 0·65-0·83) and 0·92 (95%CI:0·90-0·95), respectively. LC-SF had a high positive likelihood ratio (10·10) and a moderate negative likelihood ratio (0·27). Specifically, LC-SF had a sensitivity of 0·80 (95%CI: 0·70-0·88) and a specificity of 0·95(95%CI: 0·93-0·97) for the bacteremia outcome, and a sensitivity of 0·61 (95%CI: 0·48-0·72) and a specificity of 0·99 (95%CI: 0·99-0·99) for the fungemia outcome. High heterogeneity was found in the bacteremia outcome subgroup but not in the fungemia outcome subgroup. CONCLUSION: LC-SF is of high rule-in value for early detection of septic patients. In a population with low pretest probability, LC-SF test can still provide valuable information for ruling out bacteremia or fungemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763 · cited 1×
“We quantify the extent of between-study heterogeneity by calculating the I(2) statistics [20].”
MethodEarly goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503 · cited 1×
“A survey conducted in USA in 2000 revealed that there were more than 650 thousand of cases of sepsis annually, with an average mortality rate of 18% [1].”
Background2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
Whiting, P., Rutjes, A. W., Reitsma, J. B., Bossuyt, P. M., & Kleijnen, J. (2003) · BMC Medical Research Methodology · doi:10.1186/1471-2288-3-25 · Cited by 3,592
Pierrakos, C., & Vincent, J.-L. (2010) · Critical Care · doi:10.1186/cc8872 · Cited by 1,377 · cited 1×
“Recent advances include the development of novel clinical biomarkers [7,8], refined clinical criteria [9], intricate algorithms [10], and molecular diagnostic methods [11].”
BackgroundSystematic Reviews of Diagnostic Test Accuracy
Leeflang, M. M. G., Deeks, J. J., Gatsonis, C., & Bossuyt, P. M. M. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-12-200812160-00008 · Cited by 1,124
Research works printed but not linked: 2
- U Lodes, 2009, [Microbiological sepsis screening in surgical ICU patients with the “lightCycler” Septifast test – a pilot study], Zentralbl Chir, 134, 249
- P Diamante, 2010, Molecular diagnosis of sepsis: the experience at the Pordenone hospital, Periodico ufficiale della Società Italiana di Medicina di Laboratorio, 6, 205
Cited by
Pappas, P. G., Lionakis, M. S., Arendrup, M. C., Ostrosky-Zeichner, L., & Kullberg, B. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.26 · Cited by 1,636
Kullberg, B. J., & Arendrup, M. C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1315399 · Cited by 1,315
Bassetti, M., Azoulay, E., Kullberg, B.-J., Ruhnke, M., Shoham, S., Vazquez, J., Giacobbe, D. R., & Calandra, T. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1751 · Cited by 327
Emerging Technologies for Molecular Diagnosis of Sepsis
Sinha, M., Jupe, J., Mack, H., Coleman, T. P., Lawrence, S. M., & Fraley, S. I. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00089-17 · Cited by 331
“Another meta-analysis that included only data from journal publications reported slightly better overall sensitivity and specificity, 75% (95% CI, 65% to 83%) and 92% (95% CI, 90% to 95%), respectively, based on 8,438 tests (102).”
BackgroundPrescott, H. C., Calfee, C. S., Thompson, B. T., Angus, D. C., & Liu, V. X. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201512-2544cp · Cited by 322
Microbial diagnosis of bloodstream infection: towards molecular diagnosis directly from blood
Opota, O., Jaton, K., & Greub, G. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.02.005 · Cited by 249
“Despite its good analytic sensitivity—3 to 30 CFU/mL for bacteria and 100 CFU/mL for fungi [33,34]—the clinical sensitivity (43% to 95%) and specificity (60% to 100%) are variable [35–53].”
BackgroundChildhood diarrhoeal diseases in developing countries
Ugboko, H. U., Nwinyi, O. C., Oranusi, S. U., & Oyewale, J. O. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e03690 · Cited by 217
Molecular diagnosis of sepsis: New aspects and recent developments
Liesenfeld, O., Lehman, L., Hunfeld, K.-P., & Kost, G. (2014) · European Journal of Microbiology and Immunology · doi:10.1556/eujmi.4.2014.1.1 · Cited by 216
“Multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis – a systemic review and metaanalysis Systemic review/metaanalysis Patients with presumed sepsis [99]”
BackgroundVincent, J.-L., Brealey, D., Libert, N., Abidi, N. E., O’Dwyer, M., Zacharowski, K., Mikaszewska-Sokolewicz, M., Schrenzel, J., Simon, F., Wilks, M., et al. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000001249 · Cited by 195
White, P. L., Wingard, J. R., Bretagne, S., Löffler, J., Patterson, T. F., Slavin, M. A., Barnes, R. A., Pappas, P. G., & Donnelly, J. P. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ507 · Cited by 193
“ing Aspergillus now exist [72–77].”
Diagnosis and Treatment of Invasive Candidiasis
Barantsevich, N., & Barantsevich, E. (2022) · Antibiotics · doi:10.3390/antibiotics11060718 · Cited by 178
Diagnostics for neonatal sepsis: current approaches and future directions
Iroh Tam, P.-Y., & Bendel, C. M. (2017) · Pediatric Research · doi:10.1038/pr.2017.134 · Cited by 181
Invasive candidiasis in critical care: challenges and future directions
Logan, C., Martin-Loeches, I., & Bicanic, T. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06240-x · Cited by 180
Gosiewski, T., Ludwig-Galezowska, A. H., Huminska, K., Sroka-Oleksiak, A., Radkowski, P., Salamon, D., Wojciechowicz, J., Kus-Slowinska, M., Bulanda, M., & Wolkow, P. P. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2805-7 · Cited by 175
“Similar results obtained using SeptiFast test (Roche) demonstrated the presence of bacteria in 75 % of analyzed blood samples [17].”
ResultBloos, F., & Reinhart, K. (2014) · Virulence · doi:10.4161/viru.27393 · Cited by 167
“A recent metaanalysis to compare multiplex PCR with blood culture included 34 studies.(91) Most of the included studies addressed patients with suspected sepsis on the ICU.”
BackgroundNosocomial Candidiasis: Antifungal Stewardship and the Importance of Rapid Diagnosis
Pfaller, M. A., & Castanheira, M. (2015) · Medical Mycology · doi:10.1093/mmy/myv076 · Cited by 161
“The Roche SeptiFast real-time PCR platform has been extensively evaluated in Europe where it is CE-marked but it has not been cleared by the FDA for use in the United States [151,162].”
BackgroundMethodInfluentialAnaissie, E., & Bodey, G. P. (1989) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(20)30311-1 · Cited by 159
Culture-independent detection systems for bloodstream infection
Peri, A. M., Harris, P. N. A., & Paterson, D. L. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.09.039 · Cited by 172
T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis
Pfaller, M. A., Wolk, D. M., & Lowery, T. J. (2016) · Future Microbiology · doi:10.2217/fmb.15.111 · Cited by 157
Direct detection and drug-resistance profiling of bacteremias using inertial microfluidics
Hou, H. W., Bhattacharyya, R. P., Hung, D. T., & Han, J. (2015) · Lab on a Chip · doi:10.1039/c5lc00311c · Cited by 147
Wojno, K. J., Baunoch, D., Luke, N., Opel, M., KORMAN, H. J., Kelly, C., Jafri, S. M., Keating, P., Hazelton, D., Hindu, S., et al. (2019) · Urology · doi:10.1016/j.urology.2019.10.018 · Cited by 143
Suleyman, G., & Alangaden, G. J. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.07.008 · Cited by 167
Stevenson, M., Pandor, A., James, M. M., Rafia, R., Uttley, L., Stevens, J., Sanderson, J., Wong, R., Perkins, G. D., McMullan, R., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20460 · Cited by 144
Liu, J., Ochieng, C., Wiersma, S., Ströher, U., Towner, J. S., Whitmer, S. L. M., Nichol, S. T., Moore, C. C., Kersh, G. J., Kato, C. Y., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.02257-15 · Cited by 144
“Meta-analyses of commercial PCR tests for detecting bacteria in blood from sepsis patients reveal sensitivities of only 61% to 80% versus blood culture (29).”
BackgroundLecuit, M., & Éloit, M. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00025 · Cited by 128
Miller, R. R., Lopansri, B. K., Burke, J. P., Levy, M. M., Opal, S. M., Rothman, R. E., D’Alessio, F. R., Sidhaye, V. K., Aggarwal, N. R., BALK, R. A., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2472oc · Cited by 128
The Epidemiology and Diagnosis of Invasive Candidiasis Among Premature Infants
Kelly, M. S., Benjamin, D. K., & Smith, P. B. (2014) · Clinics in Perinatology · doi:10.1016/j.clp.2014.10.008 · Cited by 139
“Among the most studied assays for this purpose is the LightCycler SeptiFast (Roche Diagnostics GmbH, Mannheim, Germany), which can detect Candida species from whole blood in approximately 60% of patients with culture-confirmed candidemia.(78)”
Dark, P. M., Blackwood, B., Gates, S., McAuley, D. F., Perkins, G. D., McMullan, R., Wilson, C., Graham, D., Timms, K., & Warhurst, G. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3553-8 · Cited by 123
“Furthermore, we do not agree with Chang and colleagues that returning a negative SeptiFast result, even in a low prevalence population, ‘‘may justify withholding antibiotics’’ [12].”
InfluentialRadmard, S., Reid, S., Ciryam, P., Boubour, A., Ho, N., Zucker, J., Sayre, D., Greendyke, W. G., Miko, B. A., Pereira, M. R., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00281 · Cited by 127
“Multiplex molecular assays are an attractive option for detection of several microbial targets simultaneously and are now routinely used for bloodstream, respiratory, and gastrointestinal infections (12, 13).”
BackgroundLi, Y., Yang, X. H., & Zhao, W. (2017) · SLAS TECHNOLOGY · doi:10.1177/2472630317727519 · Cited by 107
Verroken, A., Defourny, L., Lechgar, L., Magnette, A., Delmée, M., & Glupczynski, Y. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2242-4 · Cited by 102
Warhurst, G., Dunn, G., Chadwick, P. R., Blackwood, B., McAuley, D. F., Perkins, G. D., McMullan, R., Gates, S., Bentley, A. M., Young, D., et al. (2015) · Health Technology Assessment · doi:10.3310/hta19350 · Cited by 92
“Chang and colleagues used a basic keyword search strategy for journal papers only, risking publication bias, and they included a number of studies that were judged not to warrant inclusion in our own review on the basis of our inclusion criterion of ‘suspected sepsis’.(88) It appears that Chang reported pooled estimat…”
BackgroundResultInfluentialChen, H., Song, F., Wang, B., Huang, H., Luo, Y., Han, X., He, H., Lin, S., Wan, L., Huang, Z., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59219-x · Cited by 105
“Particularly for the diagnosis of uncultured BSI blood samples, molecular diagnostic methods based on PCR are almost the only available technology 69,70 .”
Giacobbe, D. R., Giani, T., Bassetti, M., Marchese, A. E., Viscoli, C., & Rossolini, G. M. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.09.023 · Cited by 88
Ward, C., Stocker, K., Begum, J., Wade, P., Ebrahimsa, U., & Goldenberg, S. D. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2252-2 · Cited by 80
“Further reductions in the time to identification of organisms and provision of antimicrobial susceptibility data are now being explored using molecular techniques and automated technologies [9–23].”
MethodProcalcitonin Is a Marker of Gram-Negative Bacteremia in Patients With Sepsis
Guo, S. Y., Zhou, Y., Hu, Q. F., Yao, J., & Wang, H. (2015) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000477 · Cited by 78
“Another limitation is that the diagnostic performance of PCT was investigated only in conjunction with BC results and did not use other identification methods, such as real-time polymerase chain reaction (PCR), which may have increased the number of positive results.(21) However, the PCR technique as diagnostic tool f…”
ResultSepsis Pathogen Identification
Chun, K., Syndergaard, C., Damas, C. E., Trubey, R. K., Mukindaraj, A., Qian, S., Jin, X., Breslow, S., & Niemz, A. (2015) · SLAS TECHNOLOGY · doi:10.1177/2211068214567345 · Cited by 84
Unrevealing culture-negative severe sepsis
de Prost, N., Razazi, K., & Brun‐Buisson, C. (2013) · Critical Care · doi:10.1186/1364-8535-17-1001 · Cited by 79
Recent advances in the microbiological diagnosis of bloodstream infections
Florio, W., Morici, P., Ghelardi, E., Barnini, S., & Lupetti, A. (2017) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2017.1407745 · Cited by 82
“In another meta-analysis of 34 studies enrolling 6012 participants, the overall sensitivity and specificity of the SeptiFast assay were 0.75 (95% CI, 0.65–0.83) and 0.92 (95% CI, 0.90–0.95), respectively (Chang et al. 2013).”
BackgroundInfluentialJordana‐Lluch, E., Giménez, M., Quesada, M. D., Rivaya, B., Marcó, C., Domínguez, M. J., Arméstar, F., Martró, E., & Ausina, V. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140865 · Cited by 73
Recent advances in rapid pathogen detection method based on biosensors
Chen, Y., Wang, Z., Liu, Y., Wang, X., Li, Y., Ma, P., Gu, B., & Li, H. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3230-x · Cited by 73
Peri, A. M., Stewart, A. G., Hume, A., Irwin, A., & Harris, P. N. A. (2021) · Current Infectious Disease Reports · doi:10.1007/s11908-021-00755-0 · Cited by 80
Direct-from-Blood Detection of Pathogens: a Review of Technology and Challenges
Samuel, L. P. (2023) · Journal of Clinical Microbiology · doi:10.1128/jcm.00231-21 · Cited by 82
“evaluated 34 Septifast studies and found that the assay had high specificity but inadequate sensitivity (66).”
BackgroundMethodThe Changing Culture of the Microbiology Laboratory
Laupland, K. B., & Valiquette, L. (2013) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2013/101630 · Cited by 64
“For example, in the most studied of these for sepsis, the LightCycler SeptiFast (Roche Diagnostics, Germany) multiplex PCR, which tests for 25 common pathogens from blood samples, has been found in a recent review to have an approximate overall sensitivity of 75% and specificity of 92% for bacteremia/fungemia, with be…”
BackgroundEmerging methodologies for pathogen identification in positive blood culture testing
Dubourg, G., & Raoult, D. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2016.1112274 · Cited by 71
“A recent meta-analysis aimed at assessing the accuracy of LC-SF by reviewing the published studies.[21] The overall sensitivity and specificity for LC-SF in the detection of bacteremia or fungemia was of 75 and 92%, respectively.”
MethodUse of rapid diagnostic techniques in ICU patients with infections
Burillo, A., & Bouza, E. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0593-1 · Cited by 67
“For instance, the lack of an appropriate gold standard since blood cultures are unable to detect many true cases of infection; emphasis on microbiological rather than clinical assessment; no guidance for targeting appropriate clinical situations; and the potential for wrong interpretation of results if no expert assis…”
BackgroundPost-mortem microbiology in sudden death: sampling protocols proposed in different clinical settings
Fernández-Rodríguez, A., Burton, J. L., Andréoletti, L., Alberola, J., Fornés, P., Merino, I., Martínez, M. J., Castillo, P., Sampaio‐Maia, B., Caldas, I. M., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.08.009 · Cited by 64
Diagnosis of Bacterial Bloodstream Infections: A 16S Metagenomics Approach
Decuypere, S., Meehan, C. J., Puyvelde, S. V., de Block, T., Maltha, J., Lompo, P., Tahita, M. C., Tinto, H., Jacobs, J. A., & Deborggraeve, S. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004470 · Cited by 56
Ning, S., Liu, S., Xiao, Y., Zhang, G., Cui, W., & Reed, M. A. (2021) · Lab on a Chip · doi:10.1039/d1lc00840d · Cited by 55
Diagnosis and Treatment of Candidemia in the Intensive Care Unit
Bassetti, M., Giacobbe, D. R., Vena, A., & Wolff, M. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1693704 · Cited by 72
Warhurst, G., Maddi, S., Dunn, G., Ghrew, M. H., Chadwick, P. R., Alexander, P. D. G., Bentley, A. M., Moore, J., Sharman, M., Carlson, G., et al. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3551-x · Cited by 55
Burden of bacterial bloodstream infections and recent advances for diagnosis
Costa, S. P., & Carvalho, C. M. (2022) · Pathogens and Disease · doi:10.1093/femspd/ftac027 · Cited by 61
Lewinski, M. A., Alby, K., Babady, N. E., Butler‐Wu, S. M., Bard, J. D., Greninger, A. L., Hanson, K. E., Naccache, S. N., Newton, D. W., Temple‐Smolkin, R., et al. (2023) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2023.08.005 · Cited by 61
Improving the Diagnosis of Bloodstream Infections: PCR Coupled with Mass Spectrometry
Jordana‐Lluch, E., Giménez, M., Quesada, M. D., Ausina, V., & Martró, E. (2014) · BioMed Research International · doi:10.1155/2014/501214 · Cited by 51
Zhu, Y.-M., Ai, J., Xu, B., Cui, P., Cheng, Q., Wu, H., Qian, Y., Zhang, H., Zhou, X., Li, X., et al. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3276-5 · Cited by 51
Emerging commercial molecular tests for the diagnosis of bloodstream infection
Mwaigwisya, S., Assiri, R., & O’Grady, J. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1029459 · Cited by 49
“For bacteremia, sensitivity was 80% and specificity of 95%, whereas fungemia had 61% sensitivity and 95% specificity [51].”
BackgroundMethodNoninvasive Testing and Surrogate Markers in Invasive Fungal Diseases
Thompson, G. R., Boulware, D. R., Bahr, N. C., Clancy, C. J., Harrison, T. S., Kauffman, C. A., Le, T. P., Miceli, M. H., Mylonakis, E. E., Nguyen, M. H., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac112 · Cited by 52
“and 20 other bacterial pathogens, among patients with presumed sepsis [49].”
BackgroundAntimicrobial Stewardship in the Emergency Department
Bishop, B. M. (2015) · Journal of Pharmacy Practice · doi:10.1177/0897190015585762 · Cited by 52
“When looking specifically at bacteremia, the sensitivity and specificity increased to 80% and 95%, respectively.(40) One study found that using a PCT cutoff value of 0.”
BackgroundBalejo, R. D. P., Cortelli, J. R., Costa, F. O., Cyrino, R. M., Aquino, D. R., Cogo, K., de Miranda, T. B., Moura, S. P., & Cortelli, S. C. (2017) · Journal of Applied Oral Science · doi:10.1590/1678-7757-2017-0112 · Cited by 59
Curtoni, A., Cipriani, R., Marra, E. S., Barbui, A. M., Cavallo, R., & Costa, C. S. (2016) · Current Microbiology · doi:10.1007/s00284-016-1161-2 · Cited by 46
Prediction of Multiple Infections After Severe Burn Trauma: A Prospective Cohort Study
Yan, S., Tsurumi, A., Que, Y., Ryan, C. M., Bandyopadhaya, A., Morgan, A. A., Flaherty, P., Tompkins, R. G., & Rahme, L. G. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000759 · Cited by 51
“Several molecular early detection kits have become commercially available 400 for diagnosing common bloodstream infections, and have been found to show some promise despite of 401 much room left for improvement.(55,56) Our biomarkers on the host response may work synergistically with 402 these tests to support physici…”
Straub, J., Paula, H., Mayr, M., Kasper, D. C., Assadian, O., Berger, A., & Rittenschober-Böhm, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187688 · Cited by 44
Vardakas, K. Z., Anifantaki, F. I., Trigkidis, K., & Falagas, M. E. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2466-y · Cited by 42
“However, the pathogen panels used by such methods usually don’t include all potential responsible organisms and full susceptibility tests are not yet available [12, 13].”
BackgroundSaviauk, T., Kiiski, J., Nieminen, M. K., Tamminen, N. N., Roine, A., Kumpulainen, P. S., Hokkinen, L., Karjalainen, M., Vuento, R., Aittoniemi, J., et al. (2018) · European Surgical Research · doi:10.1159/000485461 · Cited by 42
Gosiewski, T., Flis, A., Sroka-Oleksiak, A., Kedzierska, A. E., Pietrzyk, A., Kędzierska, J., Drwiła, R., & Bulanda, M. (2014) · BMC Microbiology · doi:10.1186/s12866-014-0313-4 · Cited by 40
“The SF method did not substantiate the results in 10 cases, which can be explained by the fact that, using FISH, EUB338 probe was used, which was specific for most bacterial species, while SF identified only over a dozen of them [16], in contrast to qPCR.”
MethodResultTrung, N. T., Thau, N. S., Bang, M. H., & Song, L. H. (2019) · Scientific Reports · doi:10.1038/s41598-019-50150-y · Cited by 42
Leli, C., Cardaccia, A., Ferranti, M., Cesarini, A., D’Alò, F., Ferri, C., Cenci, E., & Mencacci, A. (2014) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2014.936493 · Cited by 39
van de Groep, K., Bos, M. P., Savelkoul, P. H. M., Rubenjan, A., Gazenbeek, C., Melchers, W. J. G., van der Poll, T., Juffermans, N. P., Ong, D. S. Y., Bonten, M. J. M., et al. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3255-1 · Cited by 40
“In fact, higher sensitivities for fungal detection have been previously reported for other molecular BSI assays, including the LSF and T2Candida tests [8, 37].”
BackgroundHecker, A., Uhle, F., Schwandner, T., Padberg, W. M., & Weigand, M. A. (2013) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-013-1132-z · Cited by 39
“For blood samples, a meta-analysis of 6,012 patients and 34 trials came to the result that the multiplex PCR systems have an adequate sensitivity and are an interesting tool for the early detection of septic patients [30].”
MethodA novel, nested, multiplex, real-time PCR for detection of bacteria and fungi in blood
Gosiewski, T., Jurkiewicz-Badacz, D., Sroka-Oleksiak, A., Brzychczy‐Włoch, M., & Bulanda, M. (2014) · BMC Microbiology · doi:10.1186/1471-2180-14-144 · Cited by 38
“in their study using SeptiFast (Roche) test, in which they demonstrated the presence of bacteria in 75% of blood samples [14].”
MethodFukumoto, H., Sato, Y., Hasegawa, H., Saeki, H., & Katano, H. (2015) · PubMed Central · Cited by 36
16S metagenomics for diagnosis of bloodstream infections: opportunities and pitfalls
Rutanga, J. P., Puyvelde, S. V., Heroes, A., Muvunyi, C. M., Jacobs, J. A., & Deborggraeve, S. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1498786 · Cited by 36
Yo, C., Shen, Y., Hsu, W., Mekary, R. A., Chen, Z. R., Lee, W.-T., Chen, S., & Lee, C. (2022) · Microbial Biotechnology · doi:10.1111/1751-7915.14124 · Cited by 50
Self-citationDark, P. M., Wilson, C., Blackwood, B., McAuley, D. F., Perkins, G. D., McMullan, R., Gates, S., & Warhurst, G. (2012) · BMJ Open · doi:10.1136/bmjopen-2011-000392 · Cited by 37
“5 recommend that SeptiFast can be used to confidently diagnose bloodstream infection [12].”
InfluentialNon-culture based assays for the detection of fungal pathogens
Otašević, S., Momčilović, S., Stojanović, N. M., Skvarč, M., Rajković, K., & Arsić-Arsenijević, V. S. (2018) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2018.03.001 · Cited by 37
Oberhettinger, P., Zieger, J., Autenrieth, I. B., Marschal, M., & Peter, S. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03828-5 · Cited by 35
Ziegler, I., Josefson, P., Olcén, P., Mölling, P., & Strålin, K. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-155 · Cited by 35
“The method has been evaluated in a systematic review [15], and was found to be specific, with a high rule-in value for the early detection of septic patients.”
MethodScerbo, M. H., Kaplan, H. B., Dua, A., Litwin, D. B., Ambrose, C. G., Moore, L. J., Murray, C. C. K., Wade, C. E., & Holcomb, J. B. (2016) · Surgical Infections · doi:10.1089/sur.2015.099 · Cited by 40
“Despite their successes, currently PCR-based approaches are only used as a supplement to, rather than a replacement for, the BC/GS analysis [68,69].”
BackgroundMethodInfluentialEnrichment of bacterial DNA for the diagnosis of blood stream infections
Trung, N. T., Hiền, T. T. T., Huyền, T. T. T., Quyen, D. T., Son, T. V., Hoan, P. Q., Phuong, N. T. K., Lien, T. T., Binh, M. T., Tong, H. V., et al. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1568-1 · Cited by 36
“Our results are in line with other studies showing that the difference between two diagnostic methodologies fluctuates from 8 % to 80 %, depending on the materials used [11, 24–28].”
ResultCosta, S. P., Dias, N., Melo, L. D. R., Azeredo, J., Santos, S. R. B., & Carvalho, C. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-62533-7 · Cited by 37
Clinical evaluation of commercial nucleic acid amplification tests in patients with suspected sepsis
Ljungström, L., Enroth, H., Claesson, B. E. B., Owemyr, I., Karlsson, J., Fröberg, B., Brodin, A.-K., Pernestig, A.-K., Jacobsson, G., Andersson, R., et al. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0938-4 · Cited by 35
“The use of different gold standards and study populations may explain observed differences in the performance characteristics [16,19,20,30].”
BackgroundMicrobiological Diagnosis of Sepsis: Polymerase Chain Reaction System Versus Blood Cultures
Suberviola, B., Márquez-López, A., Castellanos-Ortega, Á., Fernández-Mazarrasa, C., Santibáñez, M., & Martínez-Martínez, L. (2015) · American Journal of Critical Care · doi:10.4037/ajcc2016728 · Cited by 33
Direct Detection of Pathogens in Bloodstream During Sepsis: Are We There Yet?
Samuel, L. P. (2018) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2018.028274 · Cited by 39
Tröger, B., Härtel, C., Buer, J., Dördelmann, M., Felderhoff‐Müser, U., Höhn, T., Hepping, N., Hillebrand, G., Kribs, A., Marißen, J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159821 · Cited by 31
Rapszky, G. A., To, U. N. D., Kiss, V. E., Kói, T., Walter, A., Gergő, D., Meznerics, F. A., Rakovics, M., Váncsa, S., Kemény, L. V., et al. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.103028 · Cited by 43
Recent Progress in the Diagnosis of Pathogenic Candida Species in Blood Culture
Phoompoung, P., & Chayakulkeeree, M. (2016) · Mycopathologia · doi:10.1007/s11046-016-0003-x · Cited by 34
“LC-SF has a very high specificity (99 %) but a low sensitivity (61 %) [32].”
BackgroundVossen, M. G., Mitteregger, D., & Steininger, C. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.07.013 · Cited by 33
Siow, W. T., Koay, E. S.-C., Lee, C. K., Lee, H. K., Ong, V., Ngerng, W. J., Lim, H. F., Tan, A. Y., Tang, J. W.-T., & Phua, J. (2016) · Respiration · doi:10.1159/000448555 · Cited by 30
Self-citationThe EVAMICA study team, Cambau, E., Durand‐Zaleski, I., Bretagne, S., Brun‐Buisson, C., Cordonnier, C., Duval, X., Herwegh, S., Pottecher, J., Courcol, R., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4766-4 · Cited by 33
“and specificity (86%) leading to abandoning the test [19, 20].”
BackgroundMethodRecent developments in the surgical management of complex intra-abdominal infection
Soop, M., & Carlson, G. (2017) · British journal of surgery · doi:10.1002/bjs.10437 · Cited by 32
Sepsis outside intensive care unit: the other side of the coin
Mearelli, F., Orso, D., Fiotti, N., Altamura, N., Breglia, A., Nardo, M. D., Paoli, I. D., Zanetti, M., Casarsa, C., & Biolo, G. (2014) · Infection · doi:10.1007/s15010-014-0673-6 · Cited by 32
“21) and false negative results are the major concerns [77].”
BackgroundReuter, C. H., Palac, H., Kociolek, L. K., Zheng, X., Chao, Y. Y., Patel, R., & Patel, S. J. (2018) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002102 · Cited by 27
Cunha, A. P., Henriques, R., Cardoso, S., Freitas, P. P., & Carvalho, C. M. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.27841 · Cited by 26
“These include molecular methods based on DNA hybridization, such as novel polymerase chain reaction (PCR) methods (Chang et al., 2013; Peters et al., 2007; Pinheiro et al., 2016), fluorescence in situ hybridization (FISH) (Harris & Hata, 2013; Kempf et al., 2000; Parcell & Orange, 2013) and DNA…”
MethodBurdino, E., Ruggiero, T., Allice, T. G., Milia, M. G., Gregori, G., Milano, R., Cerutti, F., Rosa, F. G. D., Manno, E., Caramello, P., et al. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.03.018 · Cited by 26
“SF detection limit, as reported by the manufacturer, is 30 CFU/mL for all species, except for CoNS, Streptococcus spp., and Candida glabratawhose analytical sensitivity is 100 CFU/mL (Chang et al., 2013).”
BackgroundMethodAdvances in multiplex nucleic acid diagnostics for blood-borne pathogens: promises and pitfalls
DUNCAN, R. C., Kourout, M., Grigorenko, E. L., Fisher, C., & Dong, M. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2016.1112272 · Cited by 30
“The SeptiFast assay is the most widely studied and validated assay using direct blood samples and has yielded sensitivities ranging from 60 to 95% and specificities from 74 to 99% depending on the target pathogen.[63] The comparison of the SeptiFast system to blood culture on blood samples collected simultaneously fro…”
MethodWaldrop, G., Zucker, J., Boubour, A., Radmard, S., Green, D. A., & Thakur, K. T. (2022) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2020-0380-oa · Cited by 22
Optimizing antimicrobial therapy in critically ill patients
Pagani, L., Vitrat, V., Hautefeuille, S., Janssen, C., Bougon, D., & Sirodot, M. (2014) · Infection and Drug Resistance · doi:10.2147/idr.s44357 · Cited by 29
“negative post-test probability of 5% including bacteremia and fungi.(16)”
BackgroundProgress in the Diagnosis of Invasive Fungal Disease in Children
Warris, A., & Lehrnbecher, T. (2017) · Current Fungal Infection Reports · doi:10.1007/s12281-017-0274-9 · Cited by 24
Rutanga, J. P., & Nyirahabimana, T. (2016) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2016/6412085 · Cited by 22
“LightCycler-SeptiFast (LCSF), which is a real-time multiplex PCR test, can detect 25 common pathogens that cause BSI within few hours; as a matter of fact, LC-SF test can still provide valuable information for identifying the disease [18].”
BackgroundResultInfluentialContemporary approaches to the rapid molecular diagnosis of sepsis
Tziolos, N., & Giamarellos‐Bourboulis, E. J. (2016) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2016.1246958 · Cited by 22
“The first was published in 2013 and included 34 studies [9].”
Background
Metadata
- Authors
- Chang, S.-S., Hsieh, W.-H., Liu, T.-S., Lee, S.-H., Wang, C.-H., Chou, H.-C., Yeo, Y. H., Tseng, C.-P., & Lee, C.-C.
- Affiliations
- Chang Gung University (TW)
- National Taiwan University Hospital (TW)
- Taipei Veterans General Hospital (TW)
- National Defense Medical Center (TW)
- Harvard University (US)
- Corresponding author
- Tseng, Ching-Ping
- Lee, Chien-Chang
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-05-29
- Volume
- 8
- Issue
- 5
- Pages
- e62323
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3667030
- OpenAlex
- W2169964712
- Cited by
- 224
- References
- 58
- Citations by year
- 2026: 6 · 2025: 2 · 2024: 6 · 2023: 11 · 2022: 9 · 2021: 17 · 2020: 11 · 2019: 13 · 2018: 23 · 2017: 20 · 2016: 27 · 2015: 38 · 2014: 30 · 2013: 6
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Science Council
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and Maternal Infections
- Keywords
- sepsis, multiplex PCR, bacteremia, fungemia, bloodstream infection, diagnostic accuracy, sensitivity and specificity, real-time PCR, rapid pathogen detection
- MeSH terms
- Bacteria, DNA, Bacterial, DNA, Fungal, Fungi, Humans, Sensitivity and Specificity, Reproducibility of Results, Fungemia, Bacteremia, Multiplex Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.